← Back to patent-cliff list
Deoxycholic Acid (Noratech Pharmaceuticals)
Tier C — Watch / tradeDeoxycholic Acid (Noratech Pharmaceuticals)
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：GPCR
Indications (approved)：Submental fat accumulation
Regional status
US
-
EU
-
China
Phase III
2022-01-20
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Deoxycholic Acid (Noratech Pharmaceuticals)?
Approved indications include: Submental fat accumulation.
When does the Deoxycholic Acid (Noratech Pharmaceuticals) patent expire?
No public expiry year is available for Deoxycholic Acid (Noratech Pharmaceuticals) yet; this page updates once verified.
How do I get a quote for Deoxycholic Acid (Noratech Pharmaceuticals) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-05